Τίτλος – Title
|
Κοιλιακή Ταχυκαρδία σε Ασθενείς με Διατατική Καρδιομυοπάθεια Ventricular Tachycardia in Patients with Dilated Cardiomyopathy |
|
Συγγραφέας – Author
|
Τζωρτζ Δαδούς1, Γεώργιος Σακαντάμης2 1Λέκτορας, 2Καθηγητής, Β΄ Καρδιολογική Κλινική, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης, Θεσσαλονίκη, Ελλάς George Dadous1, Georgios Sakantamis2 1Lecturer of Cardiology, 2Professor of Cardiology, Hippokration General Hospital, 2nd Department of Cardiology, Aristotle University, Thessaloniki, Hellas |
|
Παραπομπή – Citation
|
Δαδούς,Τ., Σακαντάμης,Γ. : Κοιλιακή Ταχυκαρδία σε Ασθενείς με Διατατική Καρδιομυοπάθεια, Επιθεώρηση Κλιν. Φαρμακολ. Φαρμακοκινητ. 28: 155-163 (2010) Dadous,G., Sakantamis,G. : Ventricular Tachycardia in Patients with Dilated Cardiomyopathy, Epitheorese Klin. Farmakol. Farmakokinet. 28: 155-163 (2010) |
|
Ημερομηνία Δημοσιευσης – Publication Date
|
1 Δεκεμβρίου 2010 – 2010-12-01
|
|
Γλώσσα Πλήρους Κειμένου –
Full Text Language |
Ελληνικά – Greek |
|
Παραγγελία – Αγορά –
Order – Buy |
Ηλεκτρονική Μορφή: pdf (25 €) –
Digital Type: pdf (25 €) pharmakonpress[at]pharmakonpress[.]gr |
|
Λέξεις κλειδιά – Keywords
|
–
Dilated cardiomyopathy (DCM), conduction disease, ventricular tachycardia (VT), sudden cardiac death (SCD), arrhytmia, signal-averaged electrocardiogram (SAETG), heart rate variability (HRV), QT dispersion, T wave alternals (TWA)
|
|
Λοιποί Όροι – Other Terms
|
Άρθρο Επισκόπησης Review Article |
|
Περίληψη – Summary
|
– Ventricular Tachycardia (VT) and Sudden Cardiac Death (SCD) are most common among dilated cardiomyopathy (DCM) patients-regardless of the underlying pathology. A variety of gene mutations have been associated with the appearance of conduction disease and different mechanisms of VT have been observed with VT-BBR being the most characteristic. Signal-Averaged Electrocardiogram, Heart Rate Variability, QT dispersion and T wave alternals are useful prognostic tools, while ICD’s (Implantible Cardioverter Defibrillators) and drug therapy (ACE inhibitors, b-blockers, antiarrhythmic drugs) are the cornerstone in the treatment of VT in DCM patients. |
|
Αναφορές – References
|
1. Kass S., MacRae C., Graber H.L., et al.: A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat. Genet. 7: 546-551 (1994)
2. Jung M., Poepping I., Perrot A., et al.: Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22. Am. J. Hum. Genet. 65: 1068-1077 (1999) 3. Olson T.M., Keating T.M.: Mapping a cardiomyopathy locus on chromosome 3p22-p25. J. Clin. Invest. 97: 528-532 (1996) 4. Messina D.N., Speer M.C., Pericak-Vance M.A., McNally E.M.: Linkage of familiar dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am. J. Hum. Genet. 61: 909-917 (1997) 5. Brodsky G.L., Muntoni F., Miocic S., et al.: Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101: 473-476 (2000) 6. Luu M., Stevenson W.G., et al.: Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 80: 1675-1680 (1989) 7. De Maria R., Gavazzi A., Caroli A., et al.: Ventricular arrythmias in dialated cardiomyopathy as an independent prognostic hallmark. Am. J. Cardiol. 69: 1451-1457 (1992) 8. Romeo F., Peliccia F., Gianfrocca C., et al.: Predixtors of sudden death in idiopathic cardiomyopathy. Am. J. Cardiol. 63: 138-140 (1989) 9. Poll D.S., Marchilinski F.E., Falcone R.A., et al.: Abnormal signal-averaged electrocardiograms in patients with non-ischemic congestive cardiomyopathy: Relationship to sustained ventricular arrythmias. Circulation 72: 1308-1313 (1985) 10. Hoffmann J., Grimm W., Menz V., et al.: Heart rate variability and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Pacing Clin. Electrophyiol. 19: 1841-1844 (1996) 11. Fei L., Anderson M.H., Katritsis D., et al.: Decreased heart variability in survivors of sudden cardiac death not associated with coronary artery disease. Br. Heart J. 71: 16-21 (1994) 12. Grimm W., Steder U., Menz V., et al.: Clinical significance of increased QT dispersion in the standard 12-lead ECG for arrhythmia prediction in dilated cardiomyopathy. Pacing Clin. Electrophyiol. 19(11 pt 2): 1886-1889 (1994) 13. Adachi K., Ohnishi Y., Smima T., et al.: Determinant of microvolt T wave alternals in patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. 34: 374-380 (1999) 14. Kitamura H., Ohnishi Y., Okajima K., et al.: Onset heart rate of microvolt T wave alternals provides clinical and prognostic value in non ischemic dilated cardiomyopathy. J. Am. Coll. Cardiol. 39: 295-300 (2002) 15. Pitt B., Segal R., Martinez F.A., et al.: Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349(9054): 747-752 (1997) 16. Pitt B., Poole-Wilson P.A., Segal R., on behalf of the ELITE II Investigators: Effect of losartan compared with capropril on mortality in patients with symptomatic heart failure: Randomized trial – the Losartan Heart failure Survival Study ELITE II. Lancet 355(9215): 1582-1587 (2000) 17. Waagstein F., Hjalmarson A., Varnauskas E., Wallentin F.: Effect of chronic beta adrenergic receptor blockage in congestive cardiomyopathy. Br. Heart J. 37: 1022-1036 (2002) 18. Marks A.R., Reiken S., Marx S.O.: Progression of heart failure: Is protein protein kinase a hyperphosphorylation of the ryanodine receptor contributing factor? Circulation 105: 272-275 (2002) 19. Kukin M.L., Kalman J., Buccholz-Varley C., et al.: A direct comparisonof carvedilol and metoprolol in CHF. Circulation 8: 577 (1997) 20. Neri R., Mestroni L., Salvi A., et al.: Ventricular arrythmias in dilated cardiomyopathy: Efficacy of amiodarone. Am. Heart J. 113: 707-715 (1987) 21. DePaola A.A.V., Horowitz L.N., Spielman S.R, et al.: Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular arrytmhias treated with amiodarone. Am. J. Cardiol. 60: 276-280 1987)
|
Online ISSN 1011-6575
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση-Οδηγίες προς τους Συγγραφείς
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition-Instrunctions to Authors
Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition
Συντακτικη Επιτροπή-Editorial Board
ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ – ANNUAL SUBSCRIPTION
|
||
Γλώσσα Πλήρους Κειμένου –
Full Text Language |
Ελληνικά – Greek
|
|
Παραγγελία – Αγορά –
Order – Buy |
pharmakonpress[at]pharmakonpress[.]gr
|
|
pharmakonpress[at]pharmakonpress[.]gr
|